Quarterly rpt on consolidated results for the financial period ended 31 Dec 2025
| DUOPHARMA BIOTECH BERHAD |
| Financial Year End | 31 Dec 2025 |
| Quarter | 4 Qtr |
| Quarterly report for the financial period ended | 31 Dec 2025 |
| The figures | have not been audited |
- Default Currency
- Other Currency
Currency: Malaysian Ringgit (MYR)
SUMMARY OF KEY FINANCIAL INFORMATION
|
INDIVIDUAL PERIOD
|
CUMULATIVE PERIOD
|
||||
CURRENT YEAR QUARTER
|
PRECEDING YEAR CORRESPONDING QUARTER |
CURRENT YEAR TO DATE
|
PRECEDING YEAR CORRESPONDING PERIOD |
||
|
31 Dec 2025
|
31 Dec 2024
|
31 Dec 2025
|
31 Dec 2024
|
||
|
MYR'000
|
MYR'000
|
MYR'000
|
MYR'000
|
||
| 1 | Revenue |
224,686
|
193,671
|
931,692
|
813,695
|
| 2 | Profit/(loss) before tax |
24,906
|
17,443
|
114,909
|
80,024
|
| 3 | Profit/(loss) for the period |
19,048
|
15,083
|
87,463
|
62,645
|
| 4 | Profit/(loss) attributable to ordinary equity holders of the parent |
19,048
|
15,083
|
87,463
|
62,645
|
| 5 | Basic earnings/(loss) per share (Subunit) |
1.98
|
1.57
|
9.09
|
6.51
|
| 6 | Proposed/Declared dividend per share (Subunit) |
3.05
|
2.00
|
4.55
|
3.00
|
AS AT END OF CURRENT QUARTER
|
AS AT PRECEDING FINANCIAL YEAR END
|
||||
| 7 |
Net assets per share attributable to ordinary equity holders of the parent |
0.7900
|
0.7400
|
||
Definition of Subunit:
In a currency system, there is usually a main unit (base) and
subunit that is a fraction amount of the main unit.
Example for the subunit as follows:
| Country | Base Unit | Subunit |
| Malaysia | Ringgit | Sen |
| United States | Dollar | Cent |
| United Kingdom | Pound | Pence |
Announcement Info
| Company Name | DUOPHARMA BIOTECH BERHAD |
| Stock Name | DPHARMA |
| Date Announced | 26 Feb 2026 |
| Category | Financial Results |
| Reference Number | FRA-11022026-00001 |